Allermi: Funding, Investors & Team (Oct 2026)
Allermi is the initial company to provide personalized prescription allergy medications directly to consumers. These medications are developed by top allergists, and we aim to provide relief by giving patients access to certified allergists, evidence-based medicine, and personalized treatments.
Allermi has raised $4.8M across 3 funding rounds on record, the most recent a Series A announced in Apr 2024.
Allermi Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Allermi Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Allermi raised $1.3M in a Pre-Seed announced in Sep 2022.
6 months later, a Seed of $3.5M was announced in Mar 2023.
1.1 years later, a Series A was announced in Apr 2024 with no disclosed amount.
Allermi Founders and Leadership Team
Contact details for the Allermi team: 1 of 1 has an email address on file.
Start 14-day free trial →Allermi Funding Compared to Other Health Care Startups
Funded Startups Like Allermi in Health Care and San Francisco
Companies Similar to Allermi
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Allermi Funding FAQs
What does Allermi do?
Allermi is the initial company to provide personalized prescription allergy medications directly to consumers. These medications are developed by top allergists, and we aim to provide relief by giving patients access to certified allergists, evidence-based medicine, and personalized treatments.
How much funding has Allermi raised?
Allermi has raised $4.8M across 3 rounds on record.
When did Allermi last raise funding?
Allermi's most recent funding round on record was announced in Apr 2024. The amount was not disclosed.
Who is the CEO of Allermi?
Shani Bocian Steinberg is listed as CEO at Allermi.
Where is Allermi headquartered?
Allermi is based in San Francisco, California, United States.
How many employees does Allermi have?
Allermi is in the 1-10 employee band.
About FundedIQ's Allermi Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Allermi is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.